Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.

Ramesh S, Morrell CN, Tarango C, Thomas GD, Yuhanna IS, Girardi G, Herz J, Urbanus RT, de Groot PG, Thorpe PE, Salmon JE, Shaul PW, Mineo C.

J Clin Invest. 2011 Jan;121(1):120-31. doi: 10.1172/JCI39828. Epub 2010 Dec 1.

2.
3.

Antiphospholipid syndrome: 30 years and our contribution.

Koike T.

Int J Rheum Dis. 2015 Feb;18(2):233-41. doi: 10.1111/1756-185X.12438. Epub 2014 Dec 19. Review.

PMID:
25524556
4.

Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies.

Atsumi T, Amengual O, Yasuda S, Matsuura E, Koike T.

Autoimmunity. 2005 Aug;38(5):377-81. Review.

PMID:
16227153
5.

Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis.

Mineo C.

Curr Rheumatol Rep. 2013 May;15(5):324. doi: 10.1007/s11926-013-0324-4. Review.

6.

Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.

Yasuda S, Atsumi T, Ieko M, Koike T.

Thromb Res. 2004;114(5-6):461-5. Review.

PMID:
15507279
7.

The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity.

Xie H, Sheng L, Zhou H, Yan J.

Br J Haematol. 2014 Jan;164(2):165-76. doi: 10.1111/bjh.12587. Epub 2013 Oct 8. Review.

PMID:
24180619
8.

Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome.

Pierangeli SS, Vega-Ostertag M, Liu X, Girardi G.

Ann N Y Acad Sci. 2005 Jun;1051:413-20. Review.

PMID:
16126983
9.

Novel insights into associations of antibodies against cardiolipin and beta2-glycoprotein I with clinical features of antiphospholipid syndrome.

Shovman O, Gilburd B, Barzilai O, Langevitz P, Shoenfeld Y.

Clin Rev Allergy Immunol. 2007 Apr;32(2):145-52. Review.

PMID:
17916984
10.
11.

Antiphospholipid-mediated thrombosis: interplay between anticardiolipin antibodies and vascular cells.

López-Pedrera C, Buendía P, Barbarroja N, Siendones E, Velasco F, Cuadrado MJ.

Clin Appl Thromb Hemost. 2006 Jan;12(1):41-5. Review.

PMID:
16444433
12.

Some recent insights into the prothrombogenic mechanisms of antiphospholipid antibodies.

Todorova M, Baleva M.

Curr Med Chem. 2007;14(7):811-26. Review.

PMID:
17346165
13.

Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity.

Kuwana M.

Thromb Res. 2004;114(5-6):347-55. Review.

PMID:
15507264
14.

[Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations].

Tincani A, Casu C, Cartella S, Ziglioli T, Cattaneo R.

Reumatismo. 2010 Jan-Mar;62(1):65-75. Review. Italian.

15.

Role of anti-beta2 glycoprotein I antibodies in antiphospholipid syndrome: in vitro and in vivo studies.

Meroni PL, Ronda N, De Angelis V, Grossi C, Raschi E, Borghi MO.

Clin Rev Allergy Immunol. 2007 Feb;32(1):67-74. Review.

PMID:
17426362
16.

Antiphospholipid antibodies mediate autoimmunity against dying cells.

Andreoli L, Fredi M, Nalli C, Franceschini F, Meroni PL, Tincani A.

Autoimmunity. 2013 Aug;46(5):302-6. doi: 10.3109/08916934.2013.783025. Epub 2013 May 29. Review.

PMID:
23713583
17.

Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.

Yasuda S, Bohgaki M, Atsumi T, Koike T.

Immunobiology. 2005;210(10):775-80. Epub 2005 Oct 21. Review.

PMID:
16325497
18.

Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.

Adams M.

Semin Thromb Hemost. 2008 Apr;34(3):251-5. doi: 10.1055/s-0028-1082268. Review.

PMID:
18720304
19.
20.

Endothelial nitric oxide synthase transgenic models of endothelial dysfunction.

Atochin DN, Huang PL.

Pflugers Arch. 2010 Nov;460(6):965-74. doi: 10.1007/s00424-010-0867-4. Epub 2010 Aug 10. Review.

Supplemental Content

Support Center